The Wild and Crazy Science Around How GLP-1’s Are Reducing Cancer Risk, Improving Remission Rates, and Supporting Angiogenesis with Dr. William Li

The Wild and Crazy Science Around How GLP-1’s Are Reducing Cancer Risk, Improving Remission Rates, and Supporting Angiogenesis with Dr. William Li

July 29, 2026 · 1h 55m · Season 2 · Episode 419

About this episode

The episode discusses the transformative effects of GLP-1 medications on cancer risk and prevention with Dr. William Li.

This episode is brought to you by Tiny Health, Bon Charge, Cozy Earth, and Puori. GLP-1 medications have transformed the conversation around obesity and diabetes. But researchers are now uncovering benefits that extend far beyond weight loss. Emerging evidence suggests these drugs may influence everything from inflammation and heart health to cancer risk, opening an exciting new chapter in preventive medicine. Today on The Dhru Purohit Show, Dhru sits down with Dr. William Li to explore some of the most exciting advancements in cancer prevention, early detection, and the emerging science behind GLP-1 medications. Dr. Li breaks down cutting-edge research on how GLP-1s may help reduce cancer risk, influence cancer cells, and potentially lower the chances of recurrence and metastasis. He also unpacks the alarming rise in colon cancer, the lifestyle strategies that can help reduce your risk, his perspective on choosing the right healthcare provider, and the latest breakthroughs in cancer screening and early detection. Dr. William W. Li, MD, is an internationally renowned physician, scientist, and author of the New York Times bestsellers “Eat to Beat Disease: The New Science of How…

Sponsors

Tiny Health, Bon Charge, Cozy Earth, Puori

More episodes of Dhru Purohit Show

Explore listener stats, chart rankings, contacts and more on the Dhru Purohit Show podcast page.